- Bendeka has Orphan Drug Exclusivity until Dec. 2022
- Company does not expect generic entrants of previous version of Bendeka until Dec. 2022
- Teva is responsible for all US... read more
Arrayit Corporation (OTC: ARYC) announced on 7/02/2018 that the company has completed an allergy testing pilot program for one of nation’s largest chains of retail stores. The retailer... read more
Boehringer Ingelheim and Eli Lilly and Company (NYSE:LLY) announced today that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a... read more
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,